SCHEMBL4070408

SCHEMBL4070408

CC(=O)Oc1ccccc1C(=O)Nc1ccc(Cl)cc1C

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 6/20 0.59
▸ NPC1 O15118 4/20 0.59
▸ SMN1; SMN2 Q16637 2/20 0.59
▸ MAPT P10636 8/20 0.58
▸ KCNMA1 Q12791 3/20 0.55
▸ ALDH1A1 P00352 3/20 0.55
▸ KDM4E B2RXH2 2/20 0.55
▸ HIF1A Q16665 1/20 0.55
▸ TP53 P04637 3/20 0.52
▸ GAA P10253 2/20 0.52
▸ MEN1 O00255 1/20 0.52
▸ USP2 O75604 1/20 0.52
▸ ALOX15 P16050 1/20 0.52
▸ TSHR P16473 1/20 0.52
▸ MAPK1 P28482 1/20 0.52
▸ KMT2A Q03164 1/20 0.52
▸ GBA1 P04062 1/20 0.52
▸ HPGD P15428 1/20 0.50
▸ PKM P14618 1/20 0.49
▸ METAP2 P50579 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27631151 0.83 MAPT (0.51) RAB9ANPC1SMN1; SMN2MAPTKCNMA1
SCHEMBL4074923 0.83 MAPT (0.51) RAB9ANPC1SMN1; SMN2MAPTKCNMA1
SCHEMBL27896064 0.82 GRM5 (0.64) RAB9ANPC1MEN1MAPK1KMT2A
SCHEMBL11218564 0.80 KCNMA1 (0.71) RAB9ANPC1SMN1; SMN2MAPTKCNMA1
SCHEMBL2699617 0.80 POLB (0.55) RAB9AMAPTALDH1A1KDM4EMEN1
SCHEMBL2700484 0.80 MAPT (0.65) RAB9ANPC1SMN1; SMN2MAPTALDH1A1
SCHEMBL331634 0.79 FADS1 (0.58) RAB9ANPC1SMN1; SMN2ALDH1A1KDM4E
SCHEMBL13342741 0.77 KDM4E (0.60) MAPTALDH1A1KDM4EMEN1TSHR
SCHEMBL2700124 0.77 NPC1 (0.63) RAB9ANPC1SMN1; SMN2MAPTALDH1A1
SCHEMBL4060753 0.77 GRM8 (0.52) MAPTGBA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7507836-B2 Benzamide modulators of metabotropic glutamate receptors MERCK & CO. INC. (US) 2009-03-24 — — US disclosed
US-7507836-B2 Benzamide modulators of metabotropic glutamate receptors MERCK & CO. INC. (US) 2009-03-24 — — US disclosed
US-7507836-B2 Benzamide modulators of metabotropic glutamate receptors MERCK & CO. INC. (US) 2009-03-24 — — US disclosed
US-20060235069-A1 Benzamide modulators of metabotropic glutamate receptors MERCK SHARP & DOHME CORP. 2006-10-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060235069-A1 Benzamide modulators of metabotropic glutamate receptors GRM5, GRIK5, GRM2 RAB9A 2171/4885NPC1 2051/4885SMN1; SMN2 1372/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback